Response Patterns in Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU) Patients Treated with Omalizumab for 24 Weeks in Two Randomized, Double-Blind, Placebo-Controlled Clinical Trials (ASTERIA I and GLACIAL)

Median time to response was not reached by W24 in other treatment arms.

Saved in:
Bibliographic Details
Published in:Journal of allergy and clinical immunology Vol. 135; no. 2; p. AB127
Main Authors: Kaplan, Allen P., MD, FAAAAI, Antonova, Evgeniya, MS, PhD, Trzaskoma, Benjamin, MS, Raimundo, Karina, BPharm, MS, Rosén, Karin, MD, PhD, Omachi, Theodore A., MD, MBA, Khalil, Sam, PhD, Zazzali, James, Ph.D
Format: Journal Article
Language:English
Published: St. Louis Elsevier Limited 01-02-2015
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Median time to response was not reached by W24 in other treatment arms.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0091-6749
1097-6825
DOI:10.1016/j.jaci.2014.12.1347